(1)
FINAL HEIGHT AND ENDOCRINE COMPLICATIONS IN PATIENTS WITH ?-THALASSSEMIA INTERMEDIA: OUR EXPERIENCE IN NON-TRANSFUSED VERSUS INFREQUENTLY TRANSFUSED PATIENTS AND CORRELATIONS WITH LIVER IRON CONTENT: None. Mediterr J Hematol Infect Dis 2019, 11 (1), e2019026. https://doi.org/10.4084/mjhid.2019.026.